Cargando…
Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study
BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory tract infections among infants and young children, and is responsible for an estimated four million deaths per year globally. A monthly injection of palivizumab has been used for prophylaxis of serious RSV...
Autores principales: | Tatochenko, Vladimir, Uchaikin, Vasily, Gorelov, Aleksandr, Gudkov, Konstantin, Campbell, Andrew, Schulz, Gregory, Prahl, Rebecca, Notario, Gerard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964077/ https://www.ncbi.nlm.nih.gov/pubmed/21042555 http://dx.doi.org/10.2147/CLEP.S12279 |
Ejemplares similares
-
Comparison of risk factors between preterm and term infants hospitalized for severe respiratory syncytial virus in the Russian Federation
por: Gooch, Katherine L, et al.
Publicado: (2011) -
A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation
por: Turti, Tatyana V, et al.
Publicado: (2012) -
Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection
por: Sommer, Constanze, et al.
Publicado: (2011) -
Detection of respiratory syncytial virus & Mycoplasma pneumoniae in paediatric lower respiratory tract infections
por: Kumar, Sanchit, et al.
Publicado: (2019) -
Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons
por: Anderson, Evan J., et al.
Publicado: (2017)